Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms

Journal of Leukocyte Biology - Tập 76 Số 5 - Trang 994-1001 - 2004
Chen Guo-qian1, Jianhua Li2, Mahendar Ochani2, B. Rendon-Mitchell2, Xiaoling Qiang2, Srinivas M. Susarla2, Luis Ulloa2, Huan Yang2, Saijun Fan2, Sanna M. Goyert2, Ping Wang2, Kevin J. Tracey2, Andrew E. Sama1, Haichao Wang2,1
1Department of Emergency Medicine, North Shore University Hospital, New York University School of Medicine , Manhasset
2Center of Immunology and Inflammation, North Shore–LIJ Research Institute , Manhasset

Tóm tắt

AbstractBacterial endotoxin [lipopolysaccharide (LPS)] stimulates macrophages to sequentially release early [tumor necrosis factor (TNF)] and late [high mobility group box 1 (HMGB1)] proinflammatory cytokines. The requirement of CD14 and mitogen-activated protein kinases [MAPK; e.g., p38 and extracellular signal-regulated kinase (ERK)1/2] for endotoxin-induced TNF production has been demonstrated previously, but little is known about their involvement in endotoxin-mediated HMGB1 release. Here, we demonstrated that genetic disruption of CD14 expression abrogated LPS-induced TNF production but only partially attenuated LPS-induced HMGB1 release in cultures of primary murine peritoneal macrophages. Pharmacological suppression of p38 or ERK1/2 MAPK with specific inhibitors (SB203580, SB202190, U0126, or PD98059) significantly attenuated LPS-induced TNF production but failed to inhibit LPS-induced HMGB1 release. Consistently, an endogenous, immunosuppressive molecule, spermine, failed to inhibit LPS-induced activation of p38 MAPK and yet, still significantly attenuated LPS-mediated HMGB1 release. Direct suppression of TNF activity with neutralizing antibodies or genetic disruption of TNF expression partially attenuated HMGB1 release from macrophages induced by LPS at lower concentrations (e.g., 10 ng/ml). Taken together, these data suggest that LPS stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms.

Từ khóa


Tài liệu tham khảo

Ayala, 2000, Immune depression in polymicrobial sepsis: the role of necrotic (injured) tissue and endotoxin, Crit. Care Med., 28, 2949, 10.1097/00003246-200008000-00044

Wang, 2003, The Cytokine Handbook, 837, 10.1016/B978-012689663-3/50039-9

Dinarello, 1996, Biologic basis for interleukin-1 in disease, Blood, 87, 2095, 10.1182/blood.V87.6.2095.bloodjournal8762095

Wang, 1999, HMG-1 as a late mediator of endotoxin lethality in mice, Science, 285, 248, 10.1126/science.285.5425.248

Wright, 1990, CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein, Science, 249, 1431, 10.1126/science.1698311

Poltorak, 1998, Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene, Science, 282, 2085, 10.1126/science.282.5396.2085

Ferrero, 1993, Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide, Proc. Natl. Acad. Sci. USA, 90, 2380, 10.1073/pnas.90.6.2380

Haziot, 1996, Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice, Immunity, 4, 407, 10.1016/S1074-7613(00)80254-X

Lee, 1994, A protein kinase involved in the regulation of inflammatory cytokine biosynthesis, Nature, 372, 739, 10.1038/372739a0

Tracey, 1987, Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia, Nature, 330, 662, 10.1038/330662a0

Rendon-Mitchell, 2003, IFN-γ induces high mobility group box 1 protein release partly through a TNF-dependent mechanism, J. Immunol., 170, 3890, 10.4049/jimmunol.170.7.3890

Yang, 2004, Reversing established sepsis with antagonists of endogenous HMGB1, Proc. Natl. Acad. Sci. USA, 101, 296, 10.1073/pnas.2434651100

Wang, 2004, Extracellular role of HMGB1 in inflammation and sepsis, J. Intern. Med., 255, 320, 10.1111/j.1365-2796.2003.01302.x

Wang, 2001, HMGB1 as a late mediator of lethal systemic inflammation, Am. J. Respir. Crit. Care Med., 164, 1768, 10.1164/ajrccm.164.10.2106117

Ombrellino, 1999, Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock, Lancet, 354, 1446, 10.1016/S0140-6736(99)02658-6

Andersson, 2000, High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes, J. Exp. Med., 192, 565, 10.1084/jem.192.4.565

Park, 2003, Activation of gene expression in human neutrophils by high mobility group box 1 protein, Am. J. Physiol. Cell Physiol., 284, C870, 10.1152/ajpcell.00322.2002

Chacur, 2001, A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats, Pain, 94, 231, 10.1016/S0304-3959(01)00354-2

Sappington, 2002, HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and causes derangements in intestinal barrier function in mice, Gastroenterology, 123, 790, 10.1053/gast.2002.35391

Abraham, 2000, HMG-1 as a mediator of acute lung inflammation, J. Immunol., 165, 2950, 10.4049/jimmunol.165.6.2950

O'Connor, 2003, Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects, Cytokine, 24, 254, 10.1016/j.cyto.2003.08.001

Wang, 1997, Fetuin protects the fetus from TNF, Lancet, 350, 861, 10.1016/S0140-6736(05)62030-2

Wang, 1998, Fetuin (α2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules, Proc. Natl. Acad. Sci. USA, 95, 14429, 10.1073/pnas.95.24.14429

Gardella, 2002, The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway, EMBO Rep., 3, 995, 10.1093/embo-reports/kvf198

Bonaldi, 2003, Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion, EMBO J., 22, 5551, 10.1093/emboj/cdg516

Hambleton, 1996, Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages, Proc. Natl. Acad. Sci. USA, 93, 2774, 10.1073/pnas.93.7.2774

Moore, 2000, Divergent response to LPS and bacteria in CD14-deficient murine macrophages, J. Immunol., 165, 4272, 10.4049/jimmunol.165.8.4272

Zhang, 1997, Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response, J. Exp. Med., 185, 1759, 10.1084/jem.185.10.1759

Scaffidi, 2002, Release of chromatin protein HMGB1 by necrotic cells triggers inflammation, Nature, 418, 191, 10.1038/nature00858

Tsan, 2001, Induction of TNF-α and MnSOD by endotoxin: role of membrane CD14 and Toll-like receptor-4, Am. J. Physiol. Cell Physiol., 280, C1422, 10.1152/ajpcell.2001.280.6.C1422

Triantafilou, 2001, A CD14-independent LPS receptor cluster, Nat. Immunol., 2, 338, 10.1038/86342

Ingalls, 1995, CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide, J. Exp. Med., 181, 1473, 10.1084/jem.181.4.1473

Kobayashi, 2000, Role of macrophage scavenger receptor in endotoxin shock, J. Pathol., 192, 263, 10.1002/1096-9896(2000)9999:9999<::AID-PATH692>3.0.CO;2-U

Schromm, 1996, Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes, FEBS Lett., 399, 267, 10.1016/S0014-5793(96)01338-5

Tracey, 1986, Shock and tissue injury induced by recombinant human cachectin, Science, 234, 470, 10.1126/science.3764421

Eskandari, 1992, Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia, J. Immunol., 148, 2724, 10.4049/jimmunol.148.9.2724

Wang, 2004, Lipid unites disparate syndromes of sepsis, Nat. Med., 10, 124, 10.1038/nm0204-124

Winzen, 1999, The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism, EMBO J., 18, 4969, 10.1093/emboj/18.18.4969

Underwood, 2000, SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung, Am. J. Physiol. Lung Cell. Mol. Physiol., 279, L895, 10.1152/ajplung.2000.279.5.L895

Song, 2001, MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis, Am. J. Physiol. Cell Physiol., 281, C662, 10.1152/ajpcell.2001.281.2.C662